Introduction
============

Primary open-angle glaucoma (POAG) is a major type of glaucoma worldwide, a progressive optic neuropathy typically featuring increased intraocular pressure (IOP) and degeneration of retinal ganglion cells and fibers, with high risk of irreversible blindness [@B1], [@B2]. In patients younger than 35 years old, open-angle glaucoma is often diagnosed as juvenile open-angle glaucoma (JOAG) [@B3]. The etiology of JOAG remains unknown, but it is believed that the pathogenesis of glaucoma is multifactorial in genetic, environmental, cardiovascular, intraocular pressure-related and aging aspects, with the genetic etiology of glaucoma mostly studied [@B4], [@B5].

POAG is a critical ophthalmic issue worldwide, with over a half of all POAG patients in Asia. By 2020, it was estimated that over 73 million people would be affected by POAG [@B6]. In a cross-sectional survey of Chinese population over 40 years old in Singapore, 3.2% prevalence of POAG was observed and POAG was reported to be the leading cause of blindness [@B7]. In another study, glaucoma is also shown to be the leading cause of low vision and blindness in Taiwan [@B8]. Thus, POAG is increasingly concerned as a critical issue in ophthalmology due to its high prevalence and severe optic sequelae.

POAG was heterogeneously associated with at least 20 genetic loci, and among these loci, 11 loci were denominated as *GLC1A* to *GLC1K*, among which *GLC1A*, *GLC1E*, *GLC1G* were further identified as *myocilin* (*MYOC*), *optineurin* (*OPTN*), *WD repeat domain 36* (*WDR36*) genes, respectively [@B2]. Three loci, *WDR36*, *MYOC* and *OPTN*, have been identified as main causative genes, contributing less than 10% of all POAG etiology with *WDR36* accounting for 5% alone [@B2], [@B5]. *WDR36* gene was identified within *GLC1G* locus on 5q22.1, associated with optic neuropathies in glaucoma. Although detailed pathogenesis of mutation of *WDR36* remains unclear, genetic screening of *WDR36* gene is believed to be useful for early diagnosis of presymptomatic open-angle glaucoma in high risk individuals [@B9].

In this study, we focus on *WDR36* gene, investigating its role in JOAG, although other 6 genes have been reported to be associated with glaucoma, including *myocilin* (*MYOC*), *optineurin* (*OPTN*), *neurotrophin 4* (*NTF4*), *optic atrophy 1* (*OPA1*), *cytochrome P450, family 1, subfamily B* (*CYP1B1*), and *latent transforming growth factor-beta binding protein 2* (*LTBP2*) [@B10].

The Next-Generation Sequencing (NGS), also named Massive Parallel Sequencing, is a high-throughput DNA sequencing technology that enables scientists to analyze whole genomes or transcriptomes in a more precise but rapid manner, making great advance in genetics or in other related fields [@B11]. It is believed that more detailed genomic alteration could be detected precisely by NGS than by other conventional technologies, improving and renewing our understanding of genomic biology [@B12].

To the best of our knowledge, the causative genes *OPTN* and *MYOC*, bar *WDR36*, have been studied already in Taiwan [@B3], [@B13]. In this study, we aimed to compare variants in *WDR36* genes of JOAG patients with those of unrelated normal individuals in Taiwan, using NGS technology and comparative genetic analysis methods. Understanding the genetic correlation between JOAG and *WDR36* may have benefits to early diagnosis or treatment of this disease.

Materials and Methods
=====================

Subject Selection
-----------------

This part of subject selection is partially modified out of a previous study investigating the same set of 1210 patients for juvenile-onset open-angle glaucoma research [@B13]. In addition to the original subjects, 10 new patients who had undergone identical clinical examinations, including IOP measurement, visual-field test, slit-lamp examination and fundus examination, were added to this study.

Identification of JOAG can be established as clinical presentations of intraocular pressure (IOP) \> 22mmHg, a cup-to-disc ratio \> 0.5 or one with an asymmetric appearance, a visual field loss characteristic of glaucomatous change, and an open angle width ranging from Shaffer grade II to IV without any other apparent secondary cause like trauma or surgery. In total, 61 unrelated individuals screened were diagnosed as JOAG.

Randomly selected, another 61 individuals over 50 years old comprised the control group. Subjects of the control group also received aforementioned examinations, and glaucoma-free outcomes of the subjects were confirmed. All of 122 individuals, including 61 patients and 61 controls, belong to Han ethic origin in the study. The study protocol was approved by the Institutional Review Board of the Kuo General Hospital, conforming to the World Medical Association\'s Declaration of Helsinki (2000). All of the participants provided signed informed consent to participate in the study after the details of the study had been explained to them.

Detection of the mutations of the WDR36 gene
--------------------------------------------

Genomic DNA samples were extracted from 10ml peripheral blood collected from every participating individual and were purified by using a Gentra DNA Blood Kit (Gentra Systems, Inc. Minneapolis, USA) according to the manufacturer\'s instructions. Gel electrophoresis and spectrophotometry were applied to determine the quality and quantity of the purified DNA, respectively. Mutations in the 23 exons and flanking introns of the *WDR36* gene were screened by SOLiD^TM^ NGS sequencing (Ensembl Transcript ID. ENST00000323652).

Long range polymerase chain reaction (PCR) was applied for enrichment of *WDR36* gene, intragenic primer sequences shown in Table [1](#T1){ref-type="table"}. Cycling profile of long range PCR was conducted as follows: one cycle at 94℃ for 2 min, followed by 10 cycles at 94℃ for 10 s, at 55℃ for 30 s, and at 68℃ for 14 min, followed by 30 cycles at 94℃ for 10 s, at 55℃ for 30 s, and at 68℃ for 14 min (+20 s every cycle), followed by a final extension step at 72℃ for 5 min, according to SequalPrep^TM^ Long PCR Kit protocol (Invitrogen, USA). According to the manufacturer\'s instructions, PCR products were cleaned up using AMPure Reagent beads (Agencourt, Beverly, MA). Amplicons were pooled at an equimolar ratio, and a sequencing library was made up of 5 micrograms of DNA.

Generally, SOLiD Sequencing Analysis was then performed with the amplified genomic DNA, with the first step being preparation of fragment library, followed orderly by preparation of templated bead, SOLiD analyzer operation (sequencing) and data analysis.

Splicing site prediction by neural network
------------------------------------------

Both normal and variant *WDR36* genomic sequence of the intron 3 were analyzed by using a neural network prediction system of Berkeley Drosophila Genome Project to predict whether there were novel donor or acceptor sites [@B14].

Result
======

We screened the *WDR36* (GenBank NC_000005) of 61 JOAG patients and 61 normal Taiwanese individuals, including intronic sequence, promoter region and coding region, by PCR amplification and targeting genome sequencing analysis. In general, 27 variants were identified from 61 JOAG patients, whereas 6 variants were identified from the control group. Only one variant c.1964+2910T\>C was found in both JOAG patients and normal controls, but no significant difference in frequency was shown between the two groups, with the p value calculated by χ^2^ test being 0.862, suggesting that this variant has no direct relation to JOAG pathogenesis (Table [2](#T2){ref-type="table"}).

Among the 26 variants only found in the JOAG patients, 20 of them were established SNPs, including rs1971050, rs1993465, rs13153937, rs199945131, rs201148106, rs6859041, rs1379298, rs10038177, rs6865932, rs10045255, rs10043631, rs10038058, rs13178997, rs4957924, rs43203, rs6594498, rs7722241, rs7702774, rs4530809 and rs12520738 (Table [3](#T3){ref-type="table"}). Among those 20 SNPs, we found that only the rs13178997 (c.1494+1111G\>T) had a significant difference in frequency between JOAG patients and reference from NCBI database (p\<0.02), while there was another SNP, rs10038177 (c.710+30C\>T), which had been reported to be a risk factor for high-tension glaucoma [@B15]. The remaining 18 SNPs had no remarkable findings by comparing to the corresponding frequencies on NCBI database.

As for the other 6 novel variants, including c.460-650A\>G, c.1495-807T\>G, c.1965-2849A\>G, c.1965-2833C\>T, c.1965-2812A\>G and c.1965-2786C\>G were only found in the JOAG patients, none of them were established SNPs (Table [4](#T4){ref-type="table"}). In order to study the influence of the 6 novel variants on mRNA transcription, we utilized a neural network prediction system to predict whether there is any splicing alteration, using a cutoff of minimal score by 0.4. The variant c.460-650A\>G was the only one of the six that creates a novel acceptor site AG at c.460-644_643AG, located within intron 3 (Figure [1](#F1){ref-type="fig"}). The neural network value of the novel acceptor splicing site score was 0.5, crossing the threshold cutoff. The coding DNA sequence (CDS) of *WDR36* was translated into 952 amino acids under normal condition, whereas in c.460-650A\>G variants, the mRNA were added with 642 nucleotides within intron 3, leading to a premature termination of translation at residue 198 (TGA) (Figure [1](#F1){ref-type="fig"}). Therefore, we suggest that this variant c.460-650A\>G can cause the production of truncated proteins and further impair the function of the proteins by altering the splicing pattern, which might be one of the etiologies of JOAG.

Another 2 SNPs found in JOAG patients, c.710+30C\>T (rs10038177), reported to be a risk factor of high-tension glaucoma, and c.1494+1111G\>T (rs13178997), calculated to have significant difference in frequency between JOAG patients and the control group, were also analyzed by the neural network prediction system in the same way, which revealed no difference of splicing result in c.710+30C\>T (rs10038177). A minimal alteration of increased score of an acceptor site from 0.81 to 0.91 was detected in c.1494+1111G\>T (rs13178997) (Table [5](#T5){ref-type="table"}).

Discussion
==========

The *WDR36* gene was recognized as one of the major causative genes of POAG. Similarly, in a yeast model, *WDR36* sequence variant made a functional defect in rRNA processing that may have contributed to the development of POAG [@B16]. However, the role of *WDR36* in POAG is open to debate. Gallenberger *et al.* described in 2014 that, despite the decrease in the expression of *Wdr36* mRNA, heterozygote *Wdr36*-deficient mice showed no significant difference from wild type individuals with regards to structures, intraocular pressure, susceptibility of retinal ganglion cells to excitotoxic damage, susceptibility of optic nerve to high IOP damage, and analysis of rRNA processing [@B17]. Moreover, the role of *WDR36* in POAG had been studied in different populations. Mookherjee and colleagues investigated 10 SNPs proposed to be associated with POAG in eastern India, and found that there was little correlation between POAG and SNPs in *WDR36*, except for rs10038177 (c.710+30C\>T) which may be a risk factor for high tension glaucoma [@B15]. In Italian population, it was described that *WDR36* sequence variances play a minor role in the pathogenesis of POAG [@B18]. Also, *WDR36* was reported to be irrelevant to the development of glaucoma among German population [@B19].

Mookherjee and colleagues had studied 10 SNPs of *WDR36* (rs1971050, rs1993465, rs13153937, rs10038177, rs11241095, rs10043631, rs10038058, rs10491424, rs17553936, and rs13186912) in East Indian population that were suspected to be contributive to POAG [@B15]. In comparison, 4 SNPs (rs13186912, rs17553936, rs10491424 and rs11241095) were not identified in our patients of POAG, suggesting that these 4 variants were merely genetic polymorphisms between Indian and Taiwanese populations, with minimal role in pathogenesis of POAG.

In different ethnic groups, the frequency of *WDR36* variant varies greatly, ranging from 2.9% to 5.6% [@B10]. Moreover, different *WDR36* mutations were identified among studies. For examples, Huang *et al.* identified several mutations within *WDR36* which were mainly exons and were not found in our patients [@B10]. Likewise, Bao Jian Fan *et al.* did not find significant mutations in coding exons or splicing junctions of *WDR36* associated with POAG [@B1]. We agree with the idea that, in consistency with Jonathan *et al.* [@B20], *WDR36* may be just a modifier gene of POAG, playing a causative role in the pathogenesis of POAG to an uncertain extent.

WDR36, resembling yeast Utp21p in structure, with 14 WD40 repeats folded into two connected seven-bladed β-propellers, is known to be an essential nuclear protein localized in nucleolus that plays a critical role in the processing of 18S rRNA [@B16], [@B21]. The variety and importance of function of WDR36 had been studied. Besides heart, brain and other non-ocular organs, expression of *WDR36* were found in many of the ocular tissues, including lens, retina, optic nerve, and so on [@B9]. With *WDR36* gene deleted or depletion by RNA interference, mouse embryos die before implantation and, in human trabecular meshwork cells, apoptosis is triggered and the formation of small subunit ribosomal RNA delays [@B21]. In zebrafish models, the function of Wdr36 protein had also been studied, and it was reported that Wdr36 interacted with the p53 pathway. In POAG, apoptosis causes the loss of retinal ganglion cells, which may be in accordance with the interaction between *WDR36* and p53 pathway. However, without sufficient evidence, the *WDR36* variant alone might not be a decisive factor in the pathogenesis of POAG, but its contributory role in the disease had be discussed [@B20]. Moreover, *WDR36* was investigated by cell experiments. It had been described that WDR36 acted as a new scaffold protein, interacting with β isoform of thromboxane A2 receptor, and enhancing the interaction between Gαq and PLCβ. Despite of the unclear association between the findings and POAG, understanding the functions of *WDR36* can benefit future studies to elucidate its role in POAG [@B22].

According to NCBI database, within the amino acid sequence translated from WDR36 mRNA, it has been established that there are 2 types of conserved domain, including Utp21 and WD40. Utp21, known as an rRNA-processing protein, is one of the components of U3 snoRNP which plays an important role in 18S rRNA synthesis [@B16]. WD40, typically featuring 11-24 residues of GH dipeptide at its N-terminus and 40 residues of WD dipeptide at its C-terminus, is able to form a special propeller-like platform structure and can be found within many proteins of various functions, including signal transduction, pre-mRNA processing and cytoskeleton system [@B23]. The Utp21 conserved domain was found to be located at residue 728-948, whereas the residues associated with WD40 were identified at residue 155-420, 157-582, 332-650, 567-717 and 615-692, all of which were involved in regions behind 198, suggesting that, in c.460-650A\>G variant, the premature termination at 198 residue could lead to the loss of these conserved domains, probably inducing the apoptosis of retinal ganglion cells which is one of the pathological features of POAG.

Conclusions
===========

In summary, first, we have found a mutation c.460-650A\>G within *WDR36* which is likely to cause abnormal splicing and thus produce truncated proteins without conserved domains in Taiwanese population; further functional analysis of the mutations in this study is necessary in order to determine their exact role in POAG pathogenesis, which is also the limitation of this study. Second, by reviewing the literatures from different countries, we suggest that *WDR36* is only a subordinate factor playing a role of modifier in POAG, without consistency among races or populations.
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###### 

Oligonucleotide Primer Pairs for PCR

  Name         Oligonucleotide
  ------------ ---------------------------
  WDR36 E1F    GGGTCTGTGAGTGAATCCCTCTGTC
  WDR36 E5R    CCACAACTGCAGGCTTCCTTG
  WDR36 E5F    CAAGGAAGCCTGCAGTTGTGG
  WDR36 I10R   GCATTGATGAAACTTCCTCCAGTTG
  WDR36 I10F   CAACTGGAGGAAGTTTCATCAATGC
  WDR36 I15R   TGATCGCATCAACTCCCTGAAA
  WDR36 I15F   TTTCAGGGAGTTGATGCGATCA
  WDR36 I16R   CAACAGGGAGGAAACAGGAGGA
  WDR36 I16F   TCCTCCTGTTTCCTCCCTGTTG
  WDR36 I19R   AGCACCCTTGCCGATAAGGC
  WDR36 I19F   GCCTTATCGGCAAGGGTGCT
  WDR36 E23R   CTCCCAGAATGTCAAAAAGTG

###### 

c.1964+2910T\>C Variant Shared by JOAG Patients and Normal Individuals

            Reference Allele Count   Novel Allele Count   Novel Allele Frequency
  --------- ------------------------ -------------------- ------------------------
  JOAG      2                        3                    0.600
  Control   27                       37                   0.578
  p value   0.862                                         

###### 

Variants Found Only in Normal Individuals

  ---------------------------------------------------------------------------------------------
  HGVS Name          Allele Count   Coordinate   Chromosome Position\   SNP         
                                                 (GRCh38.p2)                        
  ------------------ -------------- ------------ ---------------------- ----------- -----------
  c.1262-223 G\>A    G:0.71         1589         13664                  111105834   rs2034896

  A:0.29             647                                                            

  c.1964+2843 A\>G   A:0.34         11           23825                  111115996   \-

  G:0.66             21                                                             

  c.1964+2865 G\>C   G:0.71         15           23847                  111116018   \-

  C:0.29             6                                                              

  c.1965-2867 A\>G   A:0.80         156          23875                  111116146   \-

  G:0.20             40                                                             

  c.1964+2918 C\>T   C:0.16         9            23900                  111116071   \-

  T:0.84             46                                                             
  ---------------------------------------------------------------------------------------------

###### 

Variants Found in JOAG Patients

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  HGVS Name         Coordinate   Position   Chromosome Position\   SNP           Allele Count and Frequency   Reference Allele Frequency   p value   
                                            (GRCh38.p2)                                                                                              
  ----------------- ------------ ---------- ---------------------- ------------- ---------------------------- ---------------------------- --------- -------
  c.330+925C\>T     1372         intron1    111093543              rs1971050     11547                        C: 0.55                      0.389     0.208

  9448              T: 0.45      0.611                                                                                                               

  c.459+221A\>G     5229         intron3    111097400              rs1993465     8871                         A: 0.69                      0.667     0.861

  4023              G: 0.31      0.333                                                                                                               

  c.460-113G\>A     6438         intron3    111098609              rs13153937    14732                        G: 0.75                      0.686     0.578

  4907              A: 0.25      0.314                                                                                                               

  c.577+624G\>T     7292         intron4    111099463              rs199945131   15                           G: 0.01                      \-        \-

  1112              T: 0.99      \-                                                                                                                  

  c.577+637T\>G     7305         intron4    111099476              rs201148106   983                          T: 0.55                      \-        \-

  793               G: 0.45      \-                                                                                                                  

  c.577+694G\>A     7362         intron4    111099533              rs6859041     8768                         G: 0.72                      0.667     0.670

  3455              A: 0.28      0.333                                                                                                               

  c.578-561T\>C     7857         intron4    111100028              rs1379298     11861                        T: 0.71                      0.617     0.458

  4918              C: 0.29      0.383                                                                                                               

  c.710+30C\>T      8581         intron5    111100751              rs10038177    2932                         C: 0.77                      0.637     0.268

  892               T: 0.23      0.363                                                                                                               

  c.710+432G\>C     8983         intron5    111101153              rs6865932     12948                        G: 0.69                      0.663     0.809

  5781              C: 0.31      0.338                                                                                                               

  c.765+259A\>G     10488        intron6    111102658              rs10045255    8709                         A: 0.70                      0.663     0.765

  3757              G: 0.30      0.337                                                                                                               

  c.1494+90C\>T     15359        intron12   111107529              rs10043631    5403                         C: 0.76                      0.617     0.221

  1688              T: 0.24      0.383                                                                                                               

  c.1494+143A\>G    15412        intron12   111107582              rs10038058    4633                         A: 0.65                      0.651     0.976

  2524              G: 0.35      0.349                                                                                                               

  c.1494+1111G\>T   16380        intron12   111108550              rs13178997    6059                         G: 0.75                      0.434     0.011

  1995              T: 0.25      0.566                                                                                                               

  c.2316+256C\>T    29226        intron19   111121397              rs4957924     4948                         C: 0.54                      0.384     0.214

  4172              T: 0.46      0.616                                                                                                               

  c.2316+1144G\>A   30114        intron19   111122285              rs43203       5569                         G: 0.61                      0.622     0.901

  3613              A: 0.39      0.378                                                                                                               

  c.2317-1152G\>A   30482        intron19   111122653              rs6594498     11061                        G: 0.78                      0.617     0.158

  3069              A: 0.22      0.383                                                                                                               

  c.2437-559T\>A    32878        intron21   111125049              rs7722241     7100                         T: 0.73                      0.711     0.885

  2657              A: 0.27      0.289                                                                                                               

  c.2437-455G\>T    32982        intron21   111125153              rs7702774     4397                         G: 0.70                      0.705     0.961

  1891              T: 0.30      0.295                                                                                                               

  c.2707-202A\>G    34361        intron22   111126532              rs4530809     3968                         A: 0.71                      0.711     0.989

  1626              G: 0.29      0.289                                                                                                               

  c.\*1045T\>G      35757        exon23     111127928              rs12520738    585                          T: 0.64                      \-        \-

  323               G: 0.36      \-                                                                                                                  

  c.460-650A\>G     5901         intron3    111098072              \-            773                          A: 0.36                      \-        \-

  1391              G: 0.64      \-                                                                                                                  

  c.1495-807T\>G    17211        intron12   111109382              \-            815                          T: 0.64                      \-        \-

  463               G: 0.36      \-                                                                                                                  

  c.1965-2849A\>G   23993        intron16   111116164              \-            2                            A: 0.10                      \-        \-

  18                G: 0.90      \-                                                                                                                  

  c.1965-2833C\>T   24009        intron16   111116180              \-            249                          C: 0.54                      \-        \-

  211               T: 0.46      \-                                                                                                                  

  c.1965-2812A\>G   24030        intron16   111116201              \-            234                          A: 0.47                      \-        \-

  263               G: 0.53      \-                                                                                                                  

  c.1965-2786C\>G   24056        intron16   111116227              \-            1                            C: 0.02                      \-        \-

  50                G: 0.98      \-                                                                                                                  

  c.1964+2910T\>C   23892        intron16   111116063              \-            2                            T: 0.40                      \-        \-

  3                 C: 0.60      \-                                                                                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Splicing Site Prediction Results of *WDR36* in Variants and Control Group

  Variant                                                Novel acceptor site prediction                         Score   Start   End
  ------------------------------------------------------ ------------------------------------------------------ ------- ------- -----
  c.460-650A\>G                                          ataaaggaccttt[A]{.ul}tgcac**AG**gtgtggtcagggttagggga   0.34    348     388
  ataaaggaccttt[G]{.ul}tgcac**AG**gtgtggtcagggttagggga   0.50                                                                   
  c.1494+1111G\>T                                        ttctatcttacgctccc[G]{.ul}t**AG**ggacatttacctacatagtt   0.81    484     524
  ttctatcttacgctccc[T]{.ul}t**AG**ggacatttacctacatagtt   0.91                                                                   
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